Clinical Trial Update: Study of the Safety and Immunogenicity of H1N1 Vaccine [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating the safety and immunogenicity of an H1N1 influenza vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H1n1 Influenza

Drugs mentioned

• H1N1 influenza vaccine (Influenza A/H1N1 vaccine)

Snippet

Sponsor: Fraunhofer, Center for Molecular Biotechnology | Conditions: H1N1 Flu | Phase 1 | Status: COMPLETED